88 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Jan 24
Entry into a Material Definitive Agreement
9:29am
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
9 Jun 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
dsgayps
5 May 23
Departure of Directors or Certain Officers
4:59pm
8-K
EX-10.1
s7mfikmngzssh7p
6 Mar 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
o78awsd0p0
28 Jan 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
tvg96 isj
17 Jul 20
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.1
g505d qk516a
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
EX-10.1
b5ipm7ta2ifrh2tirq
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
8-K
EX-10.1
80ex3r9bue4vdf8 1l
17 Dec 19
Statistically Significant Improvement Demonstrated in Moderate to Vigorous Physical Activity
8:24am
8-K
EX-10.2
11xps3x4
26 Apr 18
Entry into a Material Definitive Agreement
9:51am
8-K
EX-10.1
3kzn8fvwrsmvuu1z5
26 Apr 18
Entry into a Material Definitive Agreement
9:51am
8-K
EX-10.2
kqf8s90j9fgsbkjzj
27 Sep 17
Bellerophon Announces $23 Million Private Placement
12:00am
8-K
EX-10.1
q17mfws4v2c26ht
27 Sep 17
Bellerophon Announces $23 Million Private Placement
12:00am
8-K
EX-10.3
t0lwy
27 Sep 17
Bellerophon Announces $23 Million Private Placement
12:00am
8-K
EX-10.2
er45nzeq18bscg ze6
12 May 17
Bellerophon Announces $3.0 Million Registered Direct Offering
12:00am
8-K
EX-10.1
mwez4 whg
12 May 17
Bellerophon Announces $3.0 Million Registered Direct Offering
12:00am